+ Larger Font | - Smaller Font
Share


Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Press Release Formfactor Inc To Participate In The Sixth Annual Nyc Investor Summit 2017 is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.
Search RobinsPost News & Noticias


Press Release Formfactor Inc To Participate In The Sixth Annual Nyc Investor Summit 2017 | RobinsPost News & Noticias

FormFactor, Inc. (FORM)


Nov. 14, 2023 (GLOBE NEWSWIRE) -- FormFactor, Inc. (Nasdaq: FORM) today announced that it will be joining 14 other companies in collectively hosting the 12th Annual NYC Summit investor conference ... Read More

FormFactor, Inc. Reports 2024 First Quarter Results


DRAM probe card demand continues to be robust, and as expected, first quarter DRAM revenue reached the peak levels we last experienced in 2021,” said Mike Slessor, CEO of FormFactor, Inc. “Our ... Read More

Forbes Press Releases


In this section, you’ll find the latest Forbes press releases and news announcements. ForbesBLK has announced the speaker lineup for its second-annual ForbesBLK Summit, taking place in Atlanta ... Read More

CervoMed to Participate in Upcoming Investor Conferences


BOSTON, March 28, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ ... announced that Company’s Management will participate in the following three investor conferences during the month of April ... Read More

Gryphon Digital Mining to Participate in Upcoming Investor Conferences


This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities ... Read More

PepGen to Participate in Upcoming Investor Conferences


PepGen Inc. is a clinical-stage biotechnology company advancing the next-generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus